How has Biogen's operating lease right-of-use assets in other assets changed year-over-year?

Biogen's operating lease right-of-use assets in other assets decreased by 27.5% year-over-year, from $346.40M to $251.30M.

What is the long-term trend for Biogen's operating lease right-of-use assets in other assets?

Over 5 years (2020 to 2025), Biogen's operating lease right-of-use assets in other assets has grown at a -9.3% compound annual growth rate (CAGR), from $433.30M to $265.40M.

Non-Current Assets

Operating Lease Right-of-Use Assets in Other Assets

Biogen Operating Lease Right-of-Use Assets in Other Assets decreased by 5.3% to $251.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 27.5%, from $346.40M to $251.30M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows a downward trend with a -9.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ4 2025

Last reportedQ1 2026

Metric ID: operating_lease_rou_assets_in_other

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$402.50M	$389.10M	$375.40M	$359.00M	$321.10M	$424.50M	$403.90M	$399.10M	$366.50M	$460.90M	$420.00M	$428.10M	$389.40M	$380.40M	$356.40M	$346.40M	$334.50M	$330.50M	$265.40M	$251.30M
QoQ Change	—	-3.3%	-3.5%	-4.4%	-10.6%	+32.2%	-4.9%	-1.2%	-8.2%	+25.8%	-8.9%	+1.9%	-9.0%	-2.3%	-6.3%	-2.8%	-3.4%	-1.2%	-19.7%	-5.3%
YoY Change	—	—	—	—	-20.2%	+9.1%	+7.6%	+11.2%	+14.1%	+8.6%	+4.0%	+7.3%	+6.2%	-17.5%	-15.1%	-19.1%	-14.1%	-13.1%	-25.5%	-27.5%

Range$251.30M – $460.90M

CAGR-9.4%

Avg YoY Growth-5.3%

Median YoY Growth-4.6%

Current Streak8 quarters decline

Operating Lease Right-of-Use Assets in Other Assets at Other Companies

ALN

Alnylam PharmaceuticalsALNY View metric

Frequently Asked Questions

What is Biogen's operating lease right-of-use assets in other assets?: Biogen (BIIB) reported operating lease right-of-use assets in other assets of $251.30M in Q1 2026.
How has Biogen's operating lease right-of-use assets in other assets changed year-over-year?: Biogen's operating lease right-of-use assets in other assets decreased by 27.5% year-over-year, from $346.40M to $251.30M.
What is the long-term trend for Biogen's operating lease right-of-use assets in other assets?: Over 5 years (2020 to 2025), Biogen's operating lease right-of-use assets in other assets has grown at a -9.3% compound annual growth rate (CAGR), from $433.30M to $265.40M.